Skip to main content
Equibles

HSBC HOLDINGS PLC

Position in ZTS — Zoetis Inc.

CIK 873630 LONDON, X0
Back to ZTS Full portfolio

Position in ZTS

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$243,887,321
+$77,287,809 QoQ
Shares Held
2,063,170
+55.8% QoQ
Ownership
0.492%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.94595694974238.ToString("F0")% Shared 0.ToString("F0")% None 0.05404305025761329.ToString("F0")%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Derivatives in ZTS

reported options exposure · as of Mar 31, 2022
CallValue
$3,375,761
CallShares
17,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

HSBC HOLDINGS PLC holds $402,454,379 across 27 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (60.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
This page 		2,063,170 $243,887,321
2 UTHR
UNITED THERAPEUTICS Corp
 119,235 $70,703,969
3 TEVA
Teva Pharmaceutical Industries Ltd
 961,140 $28,949,535
4 NBIX
Neurocrine Biosciences Inc
 184,222 $24,269,403
5 VTRS
Viatris Inc
 1,715,900 $23,181,805
6 HIMS
Hims & Hers Health, Inc.
 84,159 $1,747,140
7 ALKS
Alkermes plc.
 48,337 $1,709,196
8 RDY
Dr Reddys Laboratories Ltd
 78,293 $1,084,357

All Filings in ZTS

Export CSV
42 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $243,887,321 2,063,170
2025-12-31 $166,599,512 1,324,110
2025-09-30 $163,031,640 1,114,213
2025-06-30 $163,809,095 1,050,395
2025-03-31 $185,245,732 1,125,088
2024-12-31 $185,926,583 1,141,144
2024-09-30 $225,363,202 1,153,461
2024-06-30 $222,834,162 1,285,384
2024-03-31 $204,810,760 1,210,394
2023-12-31 $166,535,471 843,773
2023-09-30 $138,087,051 793,695
2023-06-30 $122,661,390 712,278
2023-03-31 $107,391,244 645,225
2022-12-31 $122,120,401 833,302
2022-09-30 $79,307,118 534,811
2022-06-30 $90,175,208 524,610
2022-03-31 $3,375,761 17,900
2022-03-31 $91,498,768 485,173
2021-12-31 $7,857,766 32,200
2021-12-31 $129,401,051 530,267
2021-12-31 $10,078,439 41,300
2021-09-30 $6,251,308 32,200
2021-09-30 $6,193,066 31,900
2021-09-30 $111,857,833 576,171
2021-06-30 $122,300,235 656,258
2021-06-30 $6,000,792 32,200
2021-06-30 $4,677,636 25,100
2021-03-31 $138,418,140 878,957
2021-03-31 $3,748,024 23,800
2021-03-31 $1,338,580 8,500
2020-12-31 $5,676,650 34,300
2020-12-31 $10,509,250 63,500
2020-12-31 $125,406,796 757,745
2020-09-30 $10,633,291 64,300
2020-09-30 $85,474,291 516,867
2020-09-30 $5,986,394 36,200
2020-06-30 $3,604,152 26,300
2020-06-30 $59,678,175 435,480
2020-06-30 $232,968 1,700
2020-03-31 $6,355,260 54,000
2020-03-31 $2,859,867 24,300
2020-03-31 $62,167,973 528,235

Report a Problem

Category
Description
Email (optional, for follow-up)